PUBLISHER: The Business Research Company | PRODUCT CODE: 1946674
PUBLISHER: The Business Research Company | PRODUCT CODE: 1946674
Orthobiologic devices are implants made from natural cells and proteins that help accelerate healing by stimulating the regeneration of bones, cartilage, tendons, and ligaments.
The primary product categories of orthobiologics devices and equipment include demineralized bone matrix, synthetic bone substitutes, stem cell therapy, platelet-rich plasma, viscosupplementation, bone morphogenetic proteins, and synthetic orthobiologics. Stem cell therapy involves stimulating the repair and regeneration of damaged, diseased, or dysfunctional tissues using stem cells or their derivatives. The applications include osteoarthritis and degenerative arthritis, soft tissue injuries, fracture healing, maxillofacial and dental treatments, spinal fusion, trauma repair, and reconstructive surgery, and these products are used by end users such as hospitals, orthopedic clinics, and others.
Tariffs have influenced the orthobiologics market by raising costs of imported biomaterials, processing equipment, and raw biological inputs. Synthetic bone substitutes and stem cell therapy products are most affected, especially in North America and Europe. Increased costs may limit adoption in cost-sensitive healthcare settings. Positively, tariffs are promoting domestic manufacturing, local sourcing of biomaterials, and innovation in synthetic alternatives.
The orthobiologics devices and equipment market research report is one of a series of new reports from The Business Research Company that provides orthobiologics devices and equipment market statistics, including orthobiologics devices and equipment industry global market size, regional shares, competitors with a orthobiologics devices and equipment market share, detailed orthobiologics devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the orthobiologics devices and equipment industry. This orthobiologics devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The orthobiologics devices and equipment market size has grown strongly in recent years. It will grow from $5.99 billion in 2025 to $6.36 billion in 2026 at a compound annual growth rate (CAGR) of 6.2%. The growth in the historic period can be attributed to increase in musculoskeletal disorders, sports injury prevalence, orthopedic surgery growth, adoption of PRP therapies, clinical success of bone grafts.
The orthobiologics devices and equipment market size is expected to see strong growth in the next few years. It will grow to $8.64 billion in 2030 at a compound annual growth rate (CAGR) of 8.0%. The growth in the forecast period can be attributed to aging population growth, regenerative medicine innovation, minimally invasive treatment demand, reimbursement expansion, technological advancements in biomaterials. Major trends in the forecast period include rising adoption of regenerative therapies, growth in sports injury treatments, increasing use of stem cell-based products, preference for non-surgical orthopedic treatments, expansion of orthopedic clinics.
The increasing prevalence of orthopedic disorders is increasingly supporting the expansion of the orthobiologics devices and equipment market going forward. Orthopedic disorders affect the musculoskeletal system, including bones, joints, muscles, ligaments, tendons, and nerves. Demand for orthopedic treatments continues to rise due to aging populations, as older individuals are more susceptible to conditions such as osteoarthritis, osteoporosis, and fractures. Orthobiologics devices and equipment support natural tissue regeneration, enhance bone and joint repair, and improve functional recovery. These solutions contribute to improved treatment outcomes by accelerating healing and reducing recovery time. For example, in August 2023, according to the Institute for Health Metrics and Evaluation, a US-based public health research institute, approximately 15% of individuals aged 30 and older were affected by osteoarthritis in 2023, with the global affected population projected to approach 1 billion by 2050. Consequently, the rising prevalence of orthopedic disorders is reinforcing growth across the orthobiologics devices and equipment market.
Leading companies operating in the orthobiologics devices and equipment market are focusing on advanced regenerative technologies, such as synthetic bone fusion gels, to improve surgical outcomes, accelerate healing, and reduce complications. Synthetic bone fusion gels are biomaterial formulations that function as scaffolds and delivery systems for growth factors, promoting bone regeneration in orthopedic and spinal fusion procedures. For example, in January 2024, Renovos Biologics Ltd., a UK-based biomaterials company, received FDA Breakthrough Device Designation for its synthetic nanoclay bone fusion gel, Renovite BMP-2. This injectable, moldable gel is designed to localize bone morphogenetic protein-2 at the surgical site, promoting controlled bone healing while reducing the risk of ectopic bone formation and soft-tissue complications.
In January 2023, Zimmer Biomet Holdings Inc., a US-based medical technology company, acquired Embody Inc. for an undisclosed amount. This acquisition is intended to reinforce Zimmer Biomet's expanding sports medicine portfolio by integrating Embody's advanced soft-tissue healing solutions and supporting the company's long-term transformation strategy. Embody Inc. is a US-based medical device company offering collagen-based soft-tissue regeneration implants for orthobiologic applications.
Major companies operating in the orthobiologics devices and equipment market are BONESUPPORT AB, Medtronic plc, Kuros Biosciences Ltd., Stryker Corporation, Baxter International Inc., DePuy Synthes, Braun Melsungen AG, Zimmer Biomet Holdings Inc., Smith & Nephew plc, Arthrex Inc., Enovis Corp., Integra Lifesciences Holding Corporation, NuVasive Inc., Globus Medical Inc., Bioventus LLC, Orthofix Medical Inc., SeaSpine Holdings Corporation, Xtant Medical Holdings Inc., Acumed LLC, Bone Biologics Corp.
North America was the largest region in the global Ortho biologics devices and equipment market in 2025. Western Europe was the second-largest region in the orthobiologics devices and equipment market report. The regions covered in the orthobiologics devices and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the orthobiologics devices and equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The orthobiologics devices and equipment market consists of sales of demineralized bone matrix, synthetic bone substitutes, stem cell therapy, plasma-rich protein, viscosupplementation, bone morphogenetic protein, and other synthetic orthobiologics. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Orthobiologics Devices And Equipment Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses orthobiologics devices and equipment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for orthobiologics devices and equipment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The orthobiologics devices and equipment market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.